XII MEDICAL RAISES $45 MILLION IN SERIES B FINANCING TO ADVANCE BEST-IN-CLASS NEUROMODULATION THERAPY FOR OBSTRUCTIVE SLEEP APNEA

Omega Funds and Intuitive Ventures join top-tier syndicate of healthcare investors to support ongoing clinical activities UNION CITY, Calif., Aug. 21, 2024 /PRNewswire/ — XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.